In previous study, we found that the CD133+ cells displayed higher tumorigenicity and faster tumor growth compared with the CD133− cells and suggesting that CD133+ cells have the ability to initiate HCC tumor formation17. The gene discussed is PROM1; the disease is neoplasm.